Published in Am J Nephrol on February 15, 2010
Intratubular renin-angiotensin system in hypertension. Hypertension (2011) 2.14
Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy. J Investig Med (2013) 1.09
Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain. Am J Physiol Renal Physiol (2010) 1.05
Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy. Hypertension (2011) 1.05
Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease. Pflugers Arch (2012) 0.99
The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep (2012) 0.97
Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. J Diabetes Investig (2011) 0.95
Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosus. Am J Physiol Regul Integr Comp Physiol (2011) 0.89
Angiotensin II blockade and renal protection. Curr Pharm Des (2013) 0.85
Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease. Int J Clin Med (2011) 0.84
Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy. Clin Exp Nephrol (2011) 0.82
Role of the intrarenal renin-angiotensin system in the progression of renal disease. Pediatr Nephrol (2016) 0.82
Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes. Int J Nephrol Renovasc Dis (2013) 0.81
Translational studies on augmentation of intratubular renin-angiotensin system in hypertension. Kidney Int Suppl (2011) (2013) 0.80
Increased urinary angiotensinogen is an effective marker of chronic renal impairment in very low birth weight children. Clin Exp Nephrol (2013) 0.80
Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease. Int Rev Thromb (2011) 0.80
Urinary angiotensinogen level is increased in preterm neonates. Clin Exp Nephrol (2014) 0.79
Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats. Ups J Med Sci (2013) 0.78
Urinary angiotensinogen as a biomarker of nephropathy in childhood. Int J Nephrol (2011) 0.78
Urinary sodium excretion has positive correlation with activation of urinary renin angiotensin system and reactive oxygen species in hypertensive chronic kidney disease. J Korean Med Sci (2014) 0.78
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes. J Diabetes Complications (2015) 0.77
Urinary Angiotensinogen as a Potential Biomarker of Intrarenal Renin-angiotensin System Activity in Chinese Patients with Chronic Kidney Disease. West Indian Med J (2014) 0.76
Role of stimulated intrarenal angiotensinogen in hypertension. Ther Adv Cardiovasc Dis (2015) 0.76
Circulating and intrarenal renin-angiotensin systems in healthy men and nonpregnant women. Physiol Rep (2015) 0.75
Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial. PLoS One (2016) 0.75
Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients. Pediatr Nephrol (2014) 0.75
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics (1976) 13.83
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev (2007) 6.79
Molecular basis of human hypertension: role of angiotensinogen. Cell (1992) 6.07
A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr (1985) 3.35
Regulation of intrarenal angiotensin II in hypertension. Hypertension (2002) 3.34
Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension (1999) 3.33
Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol (2001) 3.23
Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension (2003) 2.99
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest (1986) 2.91
AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension (2004) 2.86
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest (1994) 2.81
Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med (1997) 2.78
In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest (1990) 2.29
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest (1997) 2.23
Effects of dietary sodium and genetic background on angiotensinogen and Renin in mouse. Hypertension (2002) 2.00
Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol (2007) 1.99
Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension (2008) 1.99
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88
Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol (2007) 1.87
Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation (1994) 1.79
Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol (2007) 1.73
Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens (2010) 1.60
In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tissue Res (1995) 1.59
Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun (2007) 1.52
Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol (1993) 1.48
Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens (2006) 1.46
Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci (2009) 1.43
Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy. Hypertension (2006) 1.41
Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest (1992) 1.28
A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. Am J Physiol Renal Physiol (2005) 1.28
Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med (1998) 1.26
Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension (1999) 1.22
Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade. J Am Soc Nephrol (1999) 1.21
Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats. Transl Res (2008) 1.14
Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int (1997) 1.08
HNF-1alpha plays an important role in IL-6-induced expression of the human angiotensinogen gene. Am J Physiol Cell Physiol (2007) 1.01
A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J Mol Med (Berl) (2005) 0.99
Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol (2008) 0.96
Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy. Kidney Int Suppl (2003) 0.96
Angiotensin II and endothelin in chronic glomerulonephritis. Kidney Int (1998) 0.86
Tissue-specific expression of renin-angiotensin system components in IgA nephropathy. Am J Nephrol (2005) 0.86
Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy. Hypertens Res (2004) 0.86
ACE inhibitors in renal disease. Kidney Int (1992) 0.85
Regulation of intrarenal angiotensin II in hypertension. Hypertension (2002) 3.34
Assessment of the helical ventricular myocardial band using standard echocardiography. Echocardiography (2014) 3.19
Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol (2012) 2.58
Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension (2004) 2.54
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol (2005) 2.25
Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol (2008) 2.15
Intratubular renin-angiotensin system in hypertension. Hypertension (2011) 2.14
Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension (2008) 2.01
Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol (2007) 1.99
Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95
AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol (2005) 1.84
Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol (2006) 1.83
Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant (2012) 1.75
Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol (2009) 1.75
Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension (2004) 1.72
Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species--ERK/JNK pathways. Hypertens Res (2010) 1.71
Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol (2009) 1.64
Intrarenal AT(1) receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol (2002) 1.59
Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol (2011) 1.58
Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension (2013) 1.52
Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system. Hypertens Res (2009) 1.51
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease. Hypertens Res (2012) 1.50
Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis (2007) 1.49
Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol (2012) 1.48
Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci (2009) 1.43
Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal regulated kinase 5 (ERK5) is involved in platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration. Hypertens Res (2007) 1.43
Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells. Am J Hypertens (2011) 1.43
Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol (2008) 1.37
Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats. Clin Exp Pharmacol Physiol (2008) 1.34
Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant (2010) 1.32
Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol (2009) 1.30
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant (2010) 1.29
Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats. Am J Physiol Renal Physiol (2011) 1.27
Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults. J Biol Chem (2002) 1.27
Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats. Int J Biol Sci (2006) 1.27
Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens (2010) 1.22
Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension. Hypertension (2008) 1.20
Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int (2004) 1.20
Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin Exp Nephrol (2013) 1.17
Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy. Biomark Insights (2009) 1.17
Neuroimaging of stroke-like episodes in MELAS. Brain Dev (2010) 1.16
The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol (2004) 1.16
Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury. Am J Physiol Renal Physiol (2007) 1.16
Collecting Duct Renin: A major player in Angiotensin II-dependent Hypertension. J Am Soc Hypertens (2010) 1.14
Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation. Circulation (2012) 1.13
Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol (2004) 1.13
Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension. Hypertension (2012) 1.12
Intrarenal angiotensin II and hypertension. Curr Hypertens Rep (2003) 1.10
Growth of head circumference in autistic infants during the first year of life. J Autism Dev Disord (2007) 1.09
Renal renin-angiotensin system. Contrib Nephrol (2004) 1.09
Bcl-2 expression modulates cell adhesion and migration promoting branching of ureteric bud cells. J Cell Physiol (2007) 1.09
Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol (2011) 1.08
Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. Am J Physiol Renal Physiol (2011) 1.08
Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes. J Pharmacol Sci (2012) 1.08
Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J (2012) 1.08
The growth factor midkine regulates the renin-angiotensin system in mice. J Clin Invest (2009) 1.06
Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells. Am J Physiol Cell Physiol (2010) 1.06
Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol (2007) 1.05
Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy. Hypertension (2011) 1.05
Megalin binds and internalizes angiotensin-(1-7). Am J Physiol Renal Physiol (2005) 1.04
Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension (2003) 1.04
Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade. J Hypertens (2010) 1.04
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. J Hypertens (2008) 1.03
IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells. Mol Cell Endocrinol (2009) 1.03
Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy. Int J Mol Sci (2013) 1.03
Hangover susceptibility in relation to aldehyde dehydrogenase-2 genotype, alcohol flushing, and mean corpuscular volume in Japanese workers. Alcohol Clin Exp Res (2005) 1.01
AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension. Am J Physiol Renal Physiol (2011) 0.99
Salt-induced renal injury in SHRs is mediated by AT1 receptor activation. J Hypertens (2011) 0.98
Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. J Pharmacol Exp Ther (2009) 0.98
The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep (2012) 0.97
Activation of the renin-angiotensin system by a low-salt diet does not augment intratubular angiotensinogen and angiotensin II in rats. Am J Physiol Renal Physiol (2013) 0.97
Proximal tubular angiotensinogen in renal biopsy suggests nondipper BP rhythm accompanied by enhanced tubular sodium reabsorption. J Hypertens (2012) 0.97
Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol (2008) 0.96
Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis. Nephrol Dial Transplant (2006) 0.96
Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. J Diabetes Investig (2011) 0.95
Activation of reactive oxygen species and the renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol (2008) 0.94
Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation. Mol Pharmacol (2004) 0.94
ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis. Am J Physiol Renal Physiol (2009) 0.94
BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kidney Int (2004) 0.94
Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte. J Hypertens (2010) 0.93
Evaluation of the GABAergic nervous system in autistic brain: (123)I-iomazenil SPECT study. Brain Dev (2011) 0.93
Myocardial strain imaging for early detection of cardiac involvement in patients with Duchenne's progressive muscular dystrophy. Echocardiography (2007) 0.92
Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats. J Hypertens (2011) 0.92
Transforming growth factor-beta1 stimulates collagen matrix remodeling through increased adhesive and contractive potential by human renal fibroblasts. Biochim Biophys Acta (2004) 0.92
Contact investigation in a primary school using a whole blood interferon-gamma assay. J Infect (2009) 0.92
Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney. J Hypertens (2012) 0.92
Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension (2011) 0.91
Short-latency somatosensory evoked potentials in infantile autism: evidence of hyperactivity in the right primary somatosensory area. Dev Med Child Neurol (2007) 0.91
Subclavian and pulmonary artery steal phenomenon in a patient with isolated left subclavian artery and right aortic arch. J Clin Ultrasound (2012) 0.91
Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. Am J Hypertens (2012) 0.91
Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts. J Pharmacol Sci (2011) 0.91